Roflumilast topical foam receives FDA approval for treating seborrheic dermatitis Dr. Kamal Kant Kohli18 Dec 2023 8:00 AM ISTUSA: Roflumilast topical foam, 0.3% has received approval from the US Food and Drug Administration (FDA), for the treatment of seborrheic dermatitis...
Oral Acitretin and TAC Effective in treatment of Oral Lichen Planus: JAMA Jacinthlyn Sylvia15 Dec 2023 7:00 PM ISTSymptomatic Oral Lichen Planus (OLP) has been a formidable challenge to treat, but a recent clinical trial revealed a positive outcome. The study from...
Study reveals Hashimoto's thyroiditis does not increase melanoma risk Medha Baranwal15 Dec 2023 10:00 AM ISTUSA: A retrospective matched cohort study found that Hashimoto's thyroiditis does not raise the risk of melanoma and nonmelanoma skin cancer...
Use of calcium channel blockers linked to more severe actinic keratosis of face and scalp Medha Baranwal14 Dec 2023 11:00 AM ISTBrazil: New research published in the International Journal of Dermatology has confirmed lower skin phototype classifications, older age, and a...
Dupilumab may reduce pruritus and lesion appearance among patients with prurigo nodularis Jacinthlyn Sylvia13 Dec 2023 5:30 AM ISTPrurigo nodularis (PN) is a distressing inflammatory skin condition marked by itchy, reddish lesions.Dupilumab may reduce pruritus and lesion...
Breakthrough in Melasma Treatment: Q-switched Nd:YAG Laser Emerges as Top Choice Dr Riya Dave12 Dec 2023 10:00 AM ISTMelasma, a challenging hyperpigmentation disorder, often poses therapeutic dilemmas due to its intricate pathogenesis, recurrence tendencies, and...
Study finds earlier onset of alopecia in women who wear the hijab Medha Baranwal11 Dec 2023 7:30 AM ISTUSA: A recent study published in the Archives of Dermatological Research has suggested an increased risk of earlier onset of alopecia in women who...
Povorcitinib Shows Positive Outcomes For Hidradenitis Suppurativa in phase 2 trial Jacinthlyn Sylvia7 Dec 2023 8:30 PM ISTA recent study published in the Journal of the American Academy of Dermatology found the potential benefits of povorcitinib, a selective oral Janus...
lntradermal heparin sodium cost-effective and less-invasive treatment than CO2 laser for early mild xanthelasma Dr Riya Dave7 Dec 2023 11:00 AM ISTXanthelasma, characterized by yellowish cholesterol deposits around the eyelids, often necessitates therapeutic interventions. Ablative CO2 laser...
Methotrexate addition to phototherapy of no benefit in treating vitiligo patients Medha Baranwal6 Dec 2023 10:45 AM ISTIran: A recent study published in Photodermatology, Photoimmunology and Photomedicine has shown no additional benefit of methotrexate addition...
Bleomycin and lidocaine delivered via needle-free EPI viable treatment of recalcitrant keloids Aditi5 Dec 2023 9:00 AM ISTKeloids are scars that extend beyond the confines of the original wound or trauma caused by chronic dermal inflammation. They can lead to physical and...
Partial CO2 laser matricectomy safe and effective treatment option for patients with pincer nail deformity Aditi4 Dec 2023 4:15 AM ISTPincer nail deformity or PND is a common toenail disorder characterized by thickening and over-curvature of the nail plate, resulting in the nail...
